tiprankstipranks
Siemens Healthineers AG (DE:SHL)
XETRA:SHL

Siemens Healthineers AG (SHL) Stock Forecast & Price Target

32 Followers
See the Price Targets and Ratings of:

SHL Analyst Ratings

Moderate Buy
11Ratings
8 Buy
3 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Siemens
Healthineers AG
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SHL Stock 12 Month Forecast

Average Price Target

€60.83
▲(13.62% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Siemens Healthineers AG in the last 3 months. The average price target is €60.83 with a high forecast of €72.75 and a low forecast of €53.89. The average price target represents a 13.62% change from the last price of €53.54.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"43":"€43","58":"€58","73":"€73","50.5":"€50.5","65.5":"€65.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":72.7476124380831,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">€72.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":60.834315,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">€60.83</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":53.887120324506,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">€53.89</span>\n  </div></div>","useHTML":true}}],"tickPositions":[43,50.5,58,65.5,73],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2023","6":"Dec<br/>2023","9":"Mar<br/>2024","12":"Jun<br/>2024","25":"Jun<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,55.1,56.457508649083316,57.81501729816663,59.172525947249945,60.53003459633326,61.88754324541657,63.245051894499895,64.60256054358321,65.96006919266652,67.31757784174984,68.67508649083315,70.03259513991647,71.39010378899978,{"y":72.7476124380831,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,55.1,55.54110115384616,55.98220230769231,56.42330346153846,56.864404615384615,57.30550576923077,57.746606923076925,58.18770807692307,58.62880923076923,59.06991038461538,59.51101153846154,59.952112692307686,60.39321384615384,{"y":60.834315,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,55.1,55.00670156342354,54.91340312684708,54.82010469027062,54.72680625369416,54.633507817117696,54.540209380541235,54.44691094396477,54.353612507388306,54.260314070811845,54.16701563423538,54.07371719765892,53.98041876108246,{"y":53.887120324506,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":51.819,"date":1686873600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.659,"date":1688688000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.375,"date":1691107200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.949,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.559,"date":1696550400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.089,"date":1698969600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.173,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.622,"date":1704412800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.545,"date":1706832000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.685,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.685,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.9,"date":1714694400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.1,"date":1717718400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€72.75Average Price Target€60.83Lowest Price Target€53.89
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Exane BNP Paribas
€63.00
Buy
17.67%
Upside
Upgraded
02/07/24
Exane BNP Paribas Upgrades Siemens Healthineers (SHL:GR) (SEMHF) to OutperformExane BNP Paribas analyst Hugo Solvet upgraded Siemens Healthineers (SHL:GR) (OTC: SEMHF) from Neutral to Outperform with a price target of EUR63.00.
Hauck & Aufhaeuser
€58.00
Buy
8.33%
Upside
Reiterated
02/02/24
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF), Teva Pharmaceutical (NYSE: TEVA) and ACADIA Pharmaceuticals (NASDAQ: ACAD)
Morgan Stanley
€59.00
Buy
10.20%
Upside
Reiterated
01/08/24
Morgan Stanley Remains a Buy on Siemens Healthineers AG (SEMHF)
HSBC
€60.00
Buy
12.07%
Upside
Reiterated
12/08/23
Siemens Healthineers (SHL:GR) (SEMHF) PT Raised to EUR60 at HSBCHSBC analyst Sezgi Oezener raised the price target on Siemens Healthineers (SHL:GR) (OTC: SEMHF) to EUR60.00 (from EUR57.00) while maintaining a Buy rating.
Citi
€61.00
Buy
13.93%
Upside
Reiterated
09/25/23
Siemens Healthineers AG (SHL:GR) (SEMHF) PT Lowered to EUR61 at CitiCiti analyst Veronika Dubajova lowered the price target on Siemens Healthineers AG (SHL:GR) (OTC: SEMHF) to EUR61.00 (from EUR65.00) while maintaining a Buy rating.

Best Analysts Covering Siemens Healthineers AG

Which Analyst Should I Follow If I Want to Buy DE:SHL and Sell After:
1 Month
Success Rate
8/12 ratings generated profit
67%
Average Return
+0.33%
reiterated a buy rating last month
Copying Graham Doyle's trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +0.33% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Success Rate
8/12 ratings generated profit
67%
Average Return
+5.11%
reiterated a buy rating last month
Copying Graham Doyle's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +5.11% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Success Rate
10/12 ratings generated profit
83%
Average Return
+4.58%
reiterated a buy rating last month
Copying Graham Doyle's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +4.58% per trade.
2 Years
Success Rate
10/12 ratings generated profit
83%
Average Return
+7.78%
reiterated a buy rating last month
Copying Graham Doyle's trades and holding each position for 2 Years would result in 83.33% of your transactions generating a profit, with an average return of +7.78% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SHL Analyst Recommendation Trends

Rating
Feb 24
Mar 24
Apr 24
May 24
Jun 24
Strong Buy
0
0
0
0
0
Buy
33
26
18
14
10
Hold
4
5
5
4
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
37
31
23
18
13
In the current month, SHL has received 10 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. SHL average Analyst price target in the past 3 months is €60.83.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

SHL Financial Forecast

SHL Earnings Forecast

Next quarter’s earnings estimate for SHL is €0.54 with a range of €0.49 to €0.59. The previous quarter’s EPS was €0.55. SHL beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 67.35% of the time in the same period. In the last calendar year SHL has Outperformed its overall industry.
Next quarter’s earnings estimate for SHL is €0.54 with a range of €0.49 to €0.59. The previous quarter’s EPS was €0.55. SHL beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 67.35% of the time in the same period. In the last calendar year SHL has Outperformed its overall industry.

SHL Sales Forecast

Next quarter’s sales forecast for SHL is €5.55B with a range of €5.49B to €5.72B. The previous quarter’s sales results were €5.43B. SHL beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 57.38% of the time in the same period. In the last calendar year SHL has Outperformed its overall industry.
Next quarter’s sales forecast for SHL is €5.55B with a range of €5.49B to €5.72B. The previous quarter’s sales results were €5.43B. SHL beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 57.38% of the time in the same period. In the last calendar year SHL has Outperformed its overall industry.

SHL Stock Forecast FAQ

What is DE:SHL’s average 12-month price target, according to analysts?
Based on analyst ratings, Siemens Healthineers AG’s 12-month average price target is €60.83.
    What is DE:SHL’s upside potential, based on the analysts’ average price target?
    Siemens Healthineers AG has 13.62% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Siemens Healthineers AG a Buy, Sell or Hold?
          Siemens Healthineers AG has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 3 hold ratings and 0 sell ratings.
            What is Siemens Healthineers AG’s share price target?
            The average share price target for Siemens Healthineers AG is €60.83. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €72.75 ,and the lowest forecast is €53.89. The average share price target represents 13.62% Increase from the current price of €53.54.
              What do analysts say about Siemens Healthineers AG?
              Siemens Healthineers AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of Siemens Healthineers AG?
                To buy shares of DE:SHL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis